THE HINDU BUSINESS LINE
Financial Daily
from THE HINDU group of publications

Friday, August 17, 2001

• AGRI-BUSINESS
• COMMODITIES
• CORPORATE
• FEATURES
• LETTERS
• MARKETS
• NEWS
• OPINION
• VARIETY
• INFO-TECH
• CATALYST
• INVESTMENT WORLD
• MONEY & BANKING
• LOGISTICS

• PAGE ONE
• INDEX
• HOME

Corporate | Next | Prev


British Bio sets up new facility in Bangalore


Our Bureau

BANGALORE, Aug. 16

THE Bangalore-based British Biologicals, a Rs 45-crore company manufacturing and marketing nutritional supplements, has set up a new manufacturing facility in Bangalore. The company has invested Rs 14 crore in the new plant from internal accruals.

The Managing Director, Mr V.S. Reddy, said the market for nutraceuticals was $45 billion globally and Rs 200 crore in India.

The company produces disease-based nutrition products, such as proteins for diabetes patients, specialised nutrition for pulmonary diseases, nutrition for pregnant and lactating women and menopausal nutrition.

The new facility is fully-automated and fulfills the Food and Drugs Administration and World Health Organisation standards, said Mr Reddy.

It has a capacity of 2.4 lakh bottles a day. ``We will invest more in the plant in the coming years,'' Mr Reddy said. The company aims to reach Rs 100 crore by 2004 and go in for a public issue after that.

Pic.: Mr V.S. Reddy, Managing Director, and Mr Bharath Reddy, Liaison Officer, UK, addressing a press conference in Bangalore on Thursday.

Picture by G.R.N. Somashekar

Comment on this article to BLFeedback@thehindu.co.in

Send this article to Friends by E-Mail


Next: Cambridge career awards presented
Prev: Efforts on to end strike at Sesa Goa
Corporate

Agri-Business | Commodities | Corporate | Features | Letters | Markets | News | Opinion | Variety | Info-Tech | Catalyst | Investment World | Money & Banking | Logistics |

Page One | Index | Home


Copyright © 2001 The Hindu Business Line.

Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line.